PD
SGMO

Point72 (DIFC)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Point72 (DIFC)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$587 Sell
871
-323
-27% -$174 ﹤0.01% 1081
2025
Q2 		$646 Sell
1,194
-23,374
-95% -$13.9K ﹤0.01% 1451
2025
Q1 		$16.1K Buy
+24,568
New +$26K ﹤0.01% 1389
2024
Q3 		– Sell
-63,840
Closed -$22.9K – 1788
2024
Q2 		$22.9K Buy
+63,840
New +$34.5K ﹤0.01% 1214

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Point72 (DIFC)'s SGMO Position: Q3 2025 in Review

Point72 (DIFC) reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 27% in Q3 2025, selling an estimated $174 and leaving 871 shares worth $587. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

Point72 (DIFC) first reported a position in SGMO in Q2 2024 and has held it in 4 quarters since. The position peaked at $22.9K in Q2 2024. 112 funds tracked by Wall St. Rank hold SGMO as of Q3 2025.

  • Point72 (DIFC) held 871 shares of SANGAMO THERAPEUTICS INC worth $587 as of Q3 2025.
  • Point72 (DIFC) sold 323 SANGAMO THERAPEUTICS INC shares in Q3 2025, an estimated $174.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #1081 holding.
  • Point72 (DIFC) first reported a position in SANGAMO THERAPEUTICS INC in Q2 2024 and has held it in 4 quarters since.
  • Point72 (DIFC)'s SANGAMO THERAPEUTICS INC position peaked at $22.9K in Q2 2024.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.